The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
The paradoxical role of IL-10 in immunity and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells
Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.10.3444 · Cited by 1,865
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“Interestingly, STAT3, the predominant downstream effector of IL-10R ligation, has been shown to be constitutively activated in different cancer models [74,75], although this has been suggested to be mediated by Epidermal growth factor receptor (EGFR) signaling [76].”
BackgroundLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
McGeachy, M. J., Bak-Jensen, K. S., Chen, Y., Tato, C. M., Blumenschein, W., McClanahan, T., & Cua, D. J. (2007) · Nature Immunology · doi:10.1038/ni1539 · Cited by 1,520
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes
Rousset, F., Garcia, E., Defrance, T., Péronne, C., Vezzio, N., Hsu, D. H., Kastelein, R., Moore, K. W., & Banchereau, J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1890 · Cited by 1,238
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
Sunderkötter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., & Sorg, C. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.3.410 · Cited by 1,120
Interleukin‐10: new perspectives on an old cytokine
Mosser, D. M., & Zhang, X. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00706.x · Cited by 1,077
Chaudhry, A., Samstein, R. M., Treuting, P., Liang, Y., Pils, M. C., Heinrich, J.-M., Jack, R. S., Wunderlich, F. T., Brüning, J. C., Müller, W., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.018 · Cited by 980
Biochemical and functional characterization of three activated macrophage populations
Edwards, J. P., Zhang, X., Frauwirth, K. A., & Mosser, D. M. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0406249 · Cited by 863
Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M. G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.19 · Cited by 777
Lo, H.-W., Hsu, S.-C., Xia, W., Cao, X., Shih, J.-Y., Wei, Y., Abbruzzese, J. L., Hortobagyi, G. N., & Hung, M.-C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0575 · Cited by 625
Jankovic, D., Kullberg, M. C., Feng, C. G., Goldszmid, R. S., Collazo, C. M., Wilson, M., Wynn, T. A., Kamanaka, M., Flavell, R. A., & Sher, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062175 · Cited by 594
Zigmond, E., Bernshtein, B., Friedlander, G., Walker, C. R., Yona, S., Kim, K.-W., Brenner, O., Krauthgamer, R., Varol, C., Müller, W., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.012 · Cited by 556
Steinbrink, K., Jonuleit, H., Müller, G., Schuler, G., Knop, J., & Enk, A. H. (1999) · Blood · doi:10.1182/blood.v93.5.1634 · Cited by 511
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Mocellin, S. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(02)00009-1 · Cited by 463
Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., & Enk, A. H. (2002) · Blood · doi:10.1182/blood.v99.7.2468 · Cited by 448
Mocikat, R., Braumüller, H., Gumy, A., Egeter, O., Ziegler, H., Reusch, U., Bubeck, A., Louis, J., Mailhammer, R., Riethmüller, G., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00264-4 · Cited by 433
Donnelly, R. P., Dickensheets, H., & Finbloom, D. S. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099313695 · Cited by 413
Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation
Maynard, C. L., & Weaver, C. T. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00711.x · Cited by 402
IL-10: a novel cytotoxic T cell differentiation factor
Chen, W. F., & Zlotnik, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.2.528 · Cited by 382
Mechanisms of interleukin‐10‐mediated immune suppression
Akdis, C. A., & Blaser, K. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01235.x · Cited by 382
Kotenko, S. V., Krause, C. D., Izotova, L. S., Pollack, B. P., Wu, W., & Pestka, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.5894 · Cited by 381
Inhibitory and Stimulatory Effects of IL-10 on Human CD8+ T Cells
Groux, H., Bigler, M., de Vries, J. E., & Roncarolo, M.-G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3188 · Cited by 376
Interleukin-10 production by effector T cells: Th1 cells show self control
Trinchieri, G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070104 · Cited by 373
Kono, K., Salazar‐Onfray, F., Petersson, M., Hansson, J., Masucci, G., Wasserman, K., Nakazawa, T., Anderson, P., & Kiessling, R. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260620 · Cited by 359
Levy, Y., & Brouet, J. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116977 · Cited by 340
A novel phenotype for an activated macrophage: the type 2 activated macrophage
Anderson, C. F., & Mosser, D. M. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.101 · Cited by 333
Expression cloning and characterization of a human IL-10 receptor.
Liu, Y., Wei, S. H., Ho, A. S. Y., de Waal Malefyt, R., & Moore, K. W. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.4.1821 · Cited by 321
Proinflammatory Effects of IL-10 During Human Endotoxemia
Lauw, F. N., Pajkrt, D., Hack, C. E., Kurimoto, M., van Deventer, S. J. H., & van der Poll, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2783 · Cited by 318
Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G., & Kiessling, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.6.2371 · Cited by 306
Interleukin 10 Receptor Signaling
Shouval, D. S., Ouahed, J., Biswas, A., Goettel, J. A., Horwitz, B. H., Klein, C., Muise, A. M., & Snapper, S. B. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00005-5 · Cited by 304
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Sato, T., Terai, M., Tamura, Y., Alexeev, V., Mastrangelo, M. J., & Selvan, S. R. (2011) · Immunologic Research · doi:10.1007/s12026-011-8262-6 · Cited by 286
Emmerich, J., Mumm, J. B., Chan, I. H., LaFace, D., Truong, H., McClanahan, T., Gorman, D. M., & Oft, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0721 · Cited by 270
Berlato, C., Cassatella, M. A., Kinjyo, I., Gatto, L., Yoshimura, A., & Bazzoni, F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6404 · Cited by 267
Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G. F. L., Laine, E., Manolio, S., & Burg, G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970516)71:4<630::aid-ijc20>3.0.co;2-e · Cited by 257
Mocellin, S., Marincola, F., Riccardo Rossi, C., Nitti, D., & Lise, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.11.001 · Cited by 247
IL-10 production by CD4+ effector T cells: a mechanism for self-regulation
Jankovic, D., Kugler, D. G., & Sher, A. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.8 · Cited by 244
Gastl, G. A., Abrams, J. S., Nanus, D. M., Oosterkamp, R., Silver, J., Liu, F., Chen, M., Albino, A. P., & Bander, N. H. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550118 · Cited by 242
Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of Tristetraprolin
Stoecklin, G., Tenenbaum, S. A., Mayo, T., Chittur, S. V., George, A. D., Baroni, T. E., Blackshear, P. J., & Anderson, P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709657200 · Cited by 238
Chen, Q., Daniel, V., Maher, D. W., & Hersey, P. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560524 · Cited by 234
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.579 · Cited by 230
Cell type-specific regulation of IL-10 expression in inflammation and disease
Hedrich, C. M., & Bream, J. H. (2010) · Immunologic Research · doi:10.1007/s12026-009-8150-5 · Cited by 218
Weber-Nordt, R. M., Riley, J. K., Greenlund, A. C., Moore, K. W., Darnell, J. E., & Schreiber, R. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27954 · Cited by 218
Cutting Edge: IL-27 Is a Potent Inducer of IL-10 but Not FoxP3 in Murine T Cells
Batten, M., Kljavin, N. M., Li, J., Walter, M. J., de Sauvage, F. J., & Ghilardi, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2752 · Cited by 208
Lucas, M., Zhang, X., Prasanna, V., & Mosser, D. M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.469 · Cited by 197
Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells
Caux, C., Massacrier, C., Vanbervliet, B., Barthelemy, C., Liu, Y.-J., & Banchereau, J. (1994) · International Immunology · doi:10.1093/intimm/6.8.1177 · Cited by 192
IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18
Cai, G., Kastelein, R. A., & Hunter, C. A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199909)29:09<2658::aid-immu2658>3.0.co;2-g · Cited by 191
The functional characterization of interleukin-10 receptor expression on human natural killer cells
Carson, W., Lindemann, M., Baiocchi, R., Linett, M., Tan, J., Chou, C., Narula, S., & Caligiuri, M. (1995) · Blood · doi:10.1182/blood.v85.12.3577.bloodjournal85123577 · Cited by 187
Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., di Pierro, F., & De Giovanni, C. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.6.3112 · Cited by 180
Itakura, E., Huang, R.-R., Wen, D.-R., Paul, E., Wünsch, P. H., & Cochran, A. J. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.5 · Cited by 174
Reprogramming of IL-10 Activity and Signaling by IFN-γ
Herrero, C., Hu, X., Li, W. P., Samuels, S., Sharif, M. N., Kotenko, S. V., & Ivashkiv, L. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5034 · Cited by 171
Braun, D. A., Fribourg, M., & Sealfon, S. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386573 · Cited by 168 · cited 2×
“This paradoxical phenomenon was brought under investigation because of the drastically different effects of IL-6 and IL-10, which are both known to activate STAT3 [23,24,26].”
BackgroundPowell, M. J., Thompson, S. A. J., Tone, Y., Waldmann, H., & Tone, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.292 · Cited by 166
Phenotype Switching in Melanoma: Implications for Progression and Therapy
Li, F. Z., Dhillon, A. S., Anderson, R. L., McArthur, G., & Ferrao, P. T. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00031 · Cited by 163
Santin, A. D., Hermonat, P. L., Ravaggi, A., Bellone, S., Pecorelli, S., Roman, J. J., Parham, G. P., & Cannon, M. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4729-4737.2000 · Cited by 161
Antimetastatic and Antitumor Activities of Interleukin 10 in a Murine Model of Breast Cancer
Kundu, N., Beaty, T. L., Jackson, M. J., & Fulton, A. M. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.8.536 · Cited by 154
Huang, S., Xie, K., Bucana, C. D., Ullrich, S. E., & Bar‐Eli, M. (1996) · PubMed · Cited by 150
Shibata, Y., Foster, L. A., Kurimoto, M., Okamura, H., Nakamura, R. M., Kawajiri, K., Justice, J. P., Scott, M. R. V., Myrvik, Q. N., & Metzger, W. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.4283 · Cited by 141
Expression of interleukin 10 in human melanoma
Krüger‐Krasagakes, S., Krasagakis, K., Garbe, C., Schmitt, E., Hüls, C., Blankenstein, T. J. F., & Diamantstein, T. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.469 · Cited by 140
Interleukin-10-mediated inhibition of free radical generation in macrophages
Dokka, S., Shi, X., Leonard, S. S., Wang, L., Castranova, V., & Rojanasakul, Y. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1196 · Cited by 137
Richter, G. H. S., Krüger‐Krasagakes, S., Hein, G., Hüls, C., Schmitt, E., Diamantstein, T., & Blankenstein, T. J. F. (1993) · PubMed · Cited by 136
Shibata, Y., Foster, L. A., Kurimoto, M., Okamura, H., Nakamura, R. M., Kawajiri, K., Justice, J. P., Scott, M. R. V., Myrvik, Q. N., & Metzger, W. J. (1998) · PubMed · Cited by 131
Nemunaitis, J. J., Fong, T. C., Shabe, P., Martineau, D., & Ando, D. G. (2001) · Cancer Investigation · doi:10.1081/cnv-100102550 · Cited by 131
Holler, E., Roncarolo, M., Hintermeíer-Knabe, R., Eißner, G., Ertl-Wagner, B. B., Schulz, U., Knabe, H., Kolb, H., Andreesen, R., & Wilmanns, W. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702126 · Cited by 121
Interleukin 10 production by human melanoma.
Sato, T., McCue, P. A., Masuoka, K., Salwen, S. A., Lattime, E. C., Mastrangelo, M. J., & Berd, D. (1996) · PubMed · Cited by 112
Rousset, F., Peyrol, S., Garcia, E., Vezzio, N., Andujar, M. B., Grimaud, J.-A., & Banchereau, J. (1995) · International Immunology · doi:10.1093/intimm/7.8.1243 · Cited by 112
A Single Amino Acid Determines the Immunostimulatory Activity of Interleukin 10
Ding, Y., Qin, L., Kotenko, S. V., Pestka, S., & Bromberg, J. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.213 · Cited by 111
Petersson, M., Charo, J., Salazar‐Onfray, F., Noffz, G., Mohaupt, M., Qin, Z., Klein, G., Blankenstein, T. J. F., & Kiessling, R. W. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2099 · Cited by 109
IL-10 Is Required for Optimal CD8 T Cell Memory following Listeria monocytogenes Infection
Foulds, K. E., Rotte, M. J., & Seder, R. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2565 · Cited by 102
Zdanov, A. S., Schalk‐Hihi, C., & Wlodawer, A. (1996) · Protein Science · doi:10.1002/pro.5560051001 · Cited by 97
Salazar‐Onfray, F., Charo, J., Petersson, M., Freland, S., Noffz, G., Qin, Z., Blankenstein, T., Ljunggren, H., & Kiessling, R. W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3195 · Cited by 89
Boyano, M. D., García-Vázquez, M. D., López-Michelena, T., Gardeazábal, J., Bilbao, J., Cañavate, M., de Galdeano, A. G., Izu, R., Díaz‐Ramón, L., Ratón, J. A., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1402 · Cited by 87
The neutrophil: one of the cellular targets of interleukin-10
Cassatella, M. A. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050036 · Cited by 84
Adris, S., Klein, S., Jasnis, M. A., Chuluyán, E., Ledda, M. F., Bravo, A., Carbone, C., Chernajovsky, Y., & Podhajcer, O. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301012 · Cited by 72
Wang, T., Ge, Y., Xiao, M., Lopez‐Coral, A., Azuma, R., Somasundaram, R., Zhang, G., Wei, Z., Xu, X., Rauscher, F. J., et al. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2012.01005.x · Cited by 69
Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas
Boulland, M., Meignin, V., Leroy, K., Copie‐Bergman, C., Brière, J., Touitou, R., Kanavaros, P., & Gaulard, P. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65667-2 · Cited by 69
Ikaros Is a Regulator of Il10 Expression in CD4+ T Cells
Umetsu, S. E., & Winandy, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901284 · Cited by 67
Allograft transduction of IL-10 prolongs survival following orthotopic liver transplantation
Shinozaki, K., Yahata, H., Tanji, H., Sakaguchi, T., Ito, H., & Dohi, K. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300881 · Cited by 64
Association between natural killer cells and regression in melanocytic lesions
McKay, K., Moore, P. C., Smoller, B. R., & Hiatt, K. M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.02.019 · Cited by 50
Li, C., Li, H., Jiang, K., Li, J., & Gai, X. (2014) · Bio-Medical Materials and Engineering · doi:10.3233/bme-130879 · Cited by 38
cmvIL-10 Stimulates the Invasive Potential of MDA-MB-231 Breast Cancer Cells
Oseguera, C. A. V., & Spencer, J. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088708 · Cited by 37
Interleukin 6 mediates production of interleukin 10 in metastatic melanoma
Terai, M., Eto, M., Young, G. D., Berd, D., Mastrangelo, M. J., Tamura, Y., Harigaya, K., & Sato, T. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1084-5 · Cited by 37
Gemelli, C., Zanocco‐Marani, T., Bicciato, S., Mazza, E. M. C., Boraschi, D., Salsi, V., Zappavigna, V., Parenti, S., Selmi, T., Tagliafico, E., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.021 · Cited by 35
Exploiting natural killer cells for therapy of melanoma
Hölsken, O., Miller, M., & Cerwenka, A. (2015) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12557 · Cited by 28
Cited by
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,118
IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
Ouyang, W., & O’Garra, A. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.020 · Cited by 1,072
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
Owen, K. L., Brockwell, N. K., & Parker, B. S. (2019) · Cancers · doi:10.3390/cancers11122002 · Cited by 714
Carlini, V., Noonan, D. M., Abdalalem, E., Goletti, D., Sansone, C., Calabrone, L., & Albini, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161067 · Cited by 543
The integration of inflammaging in age-related diseases
Fulop, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 348
Metadata
- Authors
- Mannino, M. H., Zhu, Z., Xiao, H., Bai, Q., Wakefield, M. R., & Fang, Y.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 367
- Issue
- 2
- Pages
- 103-107
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2141072599
- Cited by
- 473
- References
- 92
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.